The U.S. Food and Drug Administration has approved Amneal Pharmaceuticals' self-administered migraine drug, giving way to a ...

Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...

A first-in-human study of an investigational once-daily oral treatment for obesity (SYNT-101) demonstrates positive ...

The prescribed dosage for Breo Ellipta may depend on your individual treatment plan. Factors like your condition, medical history, age, and other treatments you take may affect your dosage of Breo ...

A first-in-human study of an investigational once-daily oral treatment for obesity (SYNT-101) demonstrated positive preliminary data for the safe and effective redirection of nutrient absorption into ...

While existing methods show significant results, such as the dramatic, long-term weight loss from bariatric surgery or the ...

Atzumi, a dihydroergotamine (DHE) nasal powder, was approved by the Food and Drug Administration (FDA) for the acute ...